DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 4, 2014-- Covidien plc (NYSE: COV) will present at the 2014 Leerink Global Healthcare Conference in New York on Feb. 12. Coleman N. Lannum, vice president, Investor Relations, will discuss the company in a presentation scheduled to begin at 11:05 a.m. ET.

A live audio webcast of the presentation can be accessed at Covidien’s Investor Relations website: http://investor.covidien.com. An archived edition of the presentation will be available following the live webcast.

About Covidien

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien develops, manufactures and sells a diverse range of industry-leading medical device and supply products. With 2013 revenue of $10.2 billion, Covidien has more than 38,000 employees worldwide in more than 70 countries, and its products are sold in over 150 countries. Please visit www.covidien.com to learn more about our business.

Source: Covidien

Covidien
External Communications
Peter Lucht, 508-452-4168
Vice President
peter.lucht@covidien.com
or
Investor Relations
Coleman Lannum, 508-452-4343
CFA, Vice President
cole.lannum@covidien.com
or
Corporate Communications
Lisa Clemence, 508-452-4375
Director
lisa.clemence@covidien.com
or
Investor Relations
Todd Carpenter, 508-452-4363
Senior Director
todd.carpenter@covidien.com